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DObjectives: Higher rates of incomplete revascularization (IR) and reduced patency are possible drawbacks of
off-pump coronary artery bypass grafting (OPCAB); both may adversely affect outcome after surgery. This
study was conducted to shed light on the relationships among IR, angiographic patency, and midterm results
after OPCAB surgery.
Methods: A total of 1604 consecutive patients underwent OPCAB during a 6-year period; 1581 patients (95%)
underwent systematic postoperative angiography. Complete follow-up was achieved in 99.5% (median, 3.2
years; up to 6.5 years). A total of 216 patients had IR (13%), and 225 had at least 1 graft failure (FitzGibbon
B or O).
Results: All the event-free survival rates for all-cause mortality (P<.001), cardiac death (P¼ .020), and major
adverse cardiac and cerebrovascular events (P<.001) were lower in the IR group. By using the Cox proportional
hazards model, IR was an independent risk factor for all-cause mortality (hazard ratio [HR], 1.80; 95% confi-
dence interval [CI], 1.15-2.81). Of those who underwent postoperative angiography, the patients with graft fail-
ure experienced reintervention more frequently than those with all grafts patent (HR, 5.49; 95% CI, 3.43-8.77).
Even with excluding patients who had undergone reintervention immediately after angiography, graft failure
was still an independent risk factor for reintervention afterwards (HR, 2.41; 95% CI, 1.30-4.47).
Conclusions: Incomplete revascularization was relevant to higher midtermmortality after OPCAB, whereas the
risk of reintervention was higher for patients with occluded grafts. Complete revascularization, coupled with
achievement of a higher patency rate, could be expected to improve follow-up outcomes after OPCAB surgery.
(J Thorac Cardiovasc Surg 2014;147:1225-32)Since the introduction of off-pump coronary artery bypass
(OPCAB), many studies have been published comparing
OPCAB with conventional coronary artery bypass
(CCAB). However, for major outcomes, such as mortality,
OPCAB has not been demonstrated to be superior to
CCAB.1 In many randomized controlled trials,2 the number
of anastomoses was fewer and the rate of complete revascu-
larization (CR) was lower in the OPCAB arm than in the
CCAB arm, except for in a few studies3; similar observations
were reported in retrospective studies.4 CR has beenwell rec-
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The Journal of Thoracic and Carhave demonstrated that incomplete revascularization (IR) is
one of the predictors of long-term mortality, even in OPCAB
patients.7,8
Patency rate is another issue with OPCAB. A recently
published, large-scale, randomized study2 reported a lower
patency rate in the OPCAB arm than in the on-pump arm on
12-month angiograms. This is partly because OPCAB is
a more technically demanding procedure than CCAB. In
fact, bypass grafting without extracorporeal circulation
carries the risk of graft failure.
Lopes et al9 have recently demonstrated that vein graft
failure 1 year after coronary artery bypass surgery is associ-
ated with an increased risk of death, myocardial infarction
(MI), or revascularization at 4 years after the angiogram.
This association is driven mostly by revascularization. Ret-
rospective studies have also reported that patients undergo-
ing OPCAB experienced reintervention more frequently at
follow-up than those undergoing CCAB,10,11 and this may
be owing to both IR and reduced patency in OPCAB.
However, the relative contribution of the 2 possible causes
has not yet been determined.10,12,13 Therefore, this study
was conducted to shed light on the associations among
IR, systematic angiographic evaluation, and midterm
results after OPCAB surgery.diovascular Surgery c Volume 147, Number 4 1225
Abbreviations and Acronyms
BITA ¼ bilateral internal thoracic artery
BSA ¼ body surface area
CCAB ¼ conventional coronary artery
bypass
COPD ¼ chronic obstructive pulmonary
disease
CI ¼ confidence interval
CR ¼ complete revascularization
CRF ¼ chronic renal failure
CT ¼ computed tomography
EuroSCORE ¼ European System for Cardiac
Operative Risk Evaluation
HR ¼ hazard ratio
IR ¼ incomplete revascularization
LAD ¼ left anterior descending
LCx ¼ left anterior circumflex
MACCE ¼ major adverse cardiac and
cerebrovascular event
MDCT ¼ multidetector computed
tomography
MI ¼ myocardial infarction
OPCAB ¼ off-pump coronary artery bypass
PCI ¼ percutaneous coronary
intervention
RCA ¼ right coronary artery
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Study Design
This was a database study using Kokura Memorial Hospital (Fukuoka,
Japan) patient medical records. The primary objective of this study was to
compare the midterm results between the CR and the IR groups. The sec-
ondary objective was to investigate the effect of angiographic patency on
midterm events. The study was approved by the KokuraMemorial Hospital
Institutional Review Board.
Patients
From January 2000 to December 2005 inclusive, 1681 patients under-
went isolated coronary artery bypass grafting by a single surgeon (H.O.)
at Kokura Memorial Hospital. Seventy-seven patients who received
CCABwere excluded, and the remaining 1604 (95%) consecutive OPCAB
patients composed the study cohort. Almost half of the CCABpatients were
in a hemodynamically unstable condition, even with an intra-aortic balloon
pump; the remaining patients had previous cardiac surgery and required
cardiopulmonary bypass for resternotomy and exposure. Six OPCAB pro-
cedures were converted to CCAB because of hemodynamic deterioration,
and they were included in the cohort of this study. All data were collected
prospectively and entered into the institutional database. The definitions of
preoperative data in this studywere based on those reported in the European
System for Cardiac Operative Risk Evaluation (EuroSCORE).14 Extracar-
diac arteriopathy includes any one or more of the following: claudication,
carotid occlusion or greater than 50% stenosis, or previous or planned
intervention on the abdominal aorta, limb arteries, or carotids.14
CR was defined according to the ‘‘traditional’’ classification described
in the Coronary Artery Surgery Study5: revascularization is incomplete,
with failure to graft into any system with significant stenosis (>50%) or1226 The Journal of Thoracic and Cardiovascular Surlack of grafting into both the left anterior descending (LAD) and circumflex
(LCx) systems for 50% or greater left main trunk disease.
Surgical Technique
All OPCAB procedures were performed under general anesthesia. The
heart was approached via median sternotomy. Heparin (100 KIU/kg and an
additional dose) was administered to achieve and maintain the activated
clotting time at more than 250 seconds. The strategies of graft selection
and distribution have been described elsewhere.15,16 In specific cases,
when distal vessels in the LCx or right coronary artery (RCA) systems
were poorly visualized on preoperative angiography, and the territories
of the vessels were deemed to have less myocardial viability based on
the results of echocardiography and/or left ventriculography, we did not
plan to place any grafts. These 98 cases were also included in the IR
group throughout the study. Endarterectomy was performed if a coronary
artery had a long, calcified plaque. Heparin was reversed with a half-
reversal dose of protamine sulfate. Oral aspirin (100 mg) was administered
from postoperative day 1 and through to and including the follow-up
period.
Angiographic Evaluation
Bypass conduits and native coronary arteries were systematically eval-
uated in 95% of patients (1422 patients) by catheter-based angiography16
or multidetector computed tomography (MDCT; SOMATOM Sensation
16; Siemens AG, Munich, Germany) before discharge with the patients’
written informed consent. The postoperative angiography was performed
as a routine evaluation, and is standard of care in Japan. Patients with
cerebrovascular disease, renal dysfunction, or respiratory failure were ex-
cluded for clinical reasons. Although all the patients underwent angiogra-
phy within the same hospitalization period as the index OPCAB, the dates
of the angiography were not available from our database. The experienced
interventional cardiologists or the radiologists reviewed the results of
graftgraphy. On catheter-based angiography, the conduit was reviewed in
at least 2 orthogonal views and scored on the worst appearance of the prox-
imal anastomosis, body of the conduit, and distal anastomosis, according to
the FitzGibbon classification.17 On MDCT, volume-rendering images and
curved multiplanar reconstruction of the anastomotic sites and conduits
were constructed to evaluate and score the patency, according to the
same classification. Based on the results of angiography, the cardiologists
and/or radiologists judged the suitability and the need for postoperative
reintervention.
Of 1521 patients who underwent angiographic evaluation, 225 (14.8%)
were identified as having at least 1 suboptimal graft (FitzGibbon B or O)
and were included in the occlusion group. The remaining 1296 patients
were identified as having all patent grafts (FitzGibbon A) and were
included in the patent group.
Follow-up
Complete follow-upwas achieved in 99.5% of cases (median, 3.2 years;
range, 1month to 6.5 years). The patientswere followed up in our outpatient
clinic at 1, 6, and 12 months after discharge and at yearly intervals thereaf-
ter. The latest information was obtained by telephone call or by the attend-
ing surgeons consulting the referring cardiologists. Eight patients were lost
to follow-up, and their data were censored at the time of the last contact, at
which point they were alive and had not had any cardiac events. Prospec-
tively gathered data on follow-up included death from any cause (including
in-hospital mortality), MI, reintervention (surgical or percutaneous coro-
nary intervention [PCI]), and stroke, which was defined as a neurological
deficit diagnosed by a neurologist and confirmed by computed tomography
(CT). Major adverse cardiac and cerebrovascular events (MACCEs) were
defined as all-cause mortality, nonfatal MI, repeated revascularization
(including in-hospital reintervention), or stroke. If more than one event
arose in one patient, only the time to the first event was analyzed.gery c April 2014
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Continuous data are expressed as means 1 SD or medians (interquar-
tile range), and categorical variables are expressed as numbers (propor-
tions). Categorical data were compared using the c2 test and the Fisher
exact test. Continuous variables were compared by the Student t-test or
the Mann-Whitney U-test, as appropriate. In the analysis of ranked data,
the Kruskal-Wallis test was performed. Multivariable logistic regression
analysis was performed to explore predictors of IR. Model variables used
in the multivariable analyses were selected a priori on the presumption
that they were clinically relevant. The model consisted of the following
22 variables: age, sex (female), body surface area (BSA), number of dis-
eased vessels (3-vessel disease or not), left main disease, 1 or more total
occluded lesion(s), congestive heart failure, previous MI, left ventricular
ejection fraction (LVEF), atrial fibrillation, chronic renal failure (CRF;
nonhemodialysis dependent or hemodialysis dependent), hypertension, hy-
percholesterolemia, diabetes mellitus (diet or oral drug use or insulin use),
chronic obstructive pulmonary disease (COPD), extracardiac arteriopathy,
cerebrovascular accident, previous PCI, previous cardiac surgery, and
emergency operation. Odds ratios with 95% confidence intervals (CIs)
were given for the logistic regression model. Survival curves were esti-
mated using the Kaplan-Meier method, and differences were demonstrated
by the log-rank test. Risk factors for midterm events were explored using
the Cox model. In addition to the covariates used in the logistic regression
model, the following 6 factors that were clinically relevant and reported by
other investigators as predictors10 were included in the analysis: conversion
to CCAB, bilateral internal thoracic arteries (BITAs), right gastroepiploic
artery, saphenous vein graft, number of anastomoses, and IR.
We also addressed potential confounding variables in the observed rela-
tionship between IR and survival through a propensity score analysis to
account for the probability of a subject experiencing IR. We estimated pro-
pensity scores as predicted probabilities from a logistic regression model
with IR as the outcome and the previously discussed covariates as predictors.
We thencreated10equal-sized strata basedon thequantiles of thepropensity
scores.The stratifiedCox regression and the stratified log-rank testwere con-
ducted to evaluate the hazard ratio (HR) for survival, with IR versus CR.
Immediately after angiography, many revascularizations were per-
formed in the occlusion group during the index hospitalization. To account
for this, another HR for the periods after discharge was calculated for rein-
tervention, in addition to the primary HR for all the reinterventions after
surgery. Both occlusion (vs patent) and the interaction between IR and oc-
clusion were tested with separate regression models.
HRs with 95% CIs were given for the Cox model. Statistical analyses
were performed using SPSS statistics, version 19.0 (IBM, Armonk, NY).
All P values quoted are 2 sided, and the significance levels were set to .05.
RESULTS
Early Results
There were 216 patients (13.5%) who underwent IR.
Table 1 presents the baseline characteristics of the 2 groups.
In the IR group, there was more 3-vessel disease (82% vs
67%; P< .001), previous MI (53% vs 42%; P ¼ .002),
and emergency operations (12% vs 7.4%; P ¼ .030). Fur-
thermore, the IR group appeared sicker, in that they had
a higher prevalence of CRF (11% vs 6.8%;P¼ .035). There
were no significant differences between the 2 groupswith re-
spect to mean age, sex, BSA, or COPD. The logistic Euro-
SCORE was higher in the IR group (4.0 vs 3.1; P<.001).
Operative and postoperative variables are also shown in
Table 1. The CR group more frequently received BITA
than the IR group (79% vs 70%; P ¼ .006). The CR group
had more anastomoses (3.8 1.1 vs 2.9 0.9; P<.001). OfThe Journal of Thoracic and Car6 emergency conversions to CCAB, 5 were in the IR group
(2.3% vs 0.1%; P<.001).
On postoperative angiography, overall graft patency (ie,
FitzGibbon A or B) was 97.5% (97.5% in the CR group
and 98.3% in the IR group; P¼ .316). The in-hospital mor-
tality rate was slightly higher in the IR group (P ¼ .085).
The distribution and patency rates for each graft in OPCAB
surgery have been described in our companion article.16
The maximum creatine kinase-myocardial band was
higher in the occlusion group than in the patent group
(median [interquartile range], 14.8 [9.5-31.8] vs 12.7 [8.4-
22.1]; P ¼ .005). Twenty patients (8.9%) in the occlusion
group experienced perioperative MI (new Q-wave and cre-
atine kinase-myocardial band, >50 IU/L), whereas 17
patients (1.3%) had perioperative MI in the patent group
(P < .0001). The rates of low cardiac output and in-
hospital mortality did not differ between the 2 groups
(P ¼ .61 and P ¼ 1.0, respectively).
Ungrafted coronary systems in the IR group were as fol-
lows: LAD in 5 patients, LCx in 61 patients, RCA in 145
patients, and both LCx and RCA in 5 patients. The reasons
for IR were the presence of a small-caliber coronary artery
in 128 patients (59%), a diffuse lesion in 20 patients (9%),
intramyocardial location in 1 patient (0.5%), and infarcted
area in 51 patients (24%). In 16 cases, no reason was given
in the operator’s note. Multivariable logistic regression
analysis was performed to identify predictors of IR; 1 or
more total occluded lesion(s), BSA, 3-vessel disease, emer-
gency operation, diabetes mellitus (diet or oral drug use),
and female sex were identified as predictors of IR (Table 2).
Midterm Data
During the follow-up, 184 patients died: 61 from cardiac
causes (23 sudden deaths) and 123 from noncardiac causes.
Six patients experienced acuteMI, and 29 developed stroke.
Ninety-four patients received reintervention procedures: 24
received PCI during the same hospitalization as the index
OPCAB, 66 underwent PCI after discharge, and 4 had reop-
erations (1 as an in-hospital redo surgery).
Figure 1, A, shows the Kaplan-Meier curves for all-cause
mortality. The 5-year survival rates were 74.9%  3.7% for
the IR group and 84.9%  1.4% for the CR group (log-rank
test, P<.001). As presented in Figure 1, B, there were more
deaths fromcardiac causes in the IRgroup than in theCRgroup
(P¼ .020). The disease-free survival rates for cardiac death af-
ter 5 years were 91.5% 2.4% in the IR group and 94.4%
0.9% in the CR group. The event-free survival rate for
MACCE was significantly lower in the IR group (66.0% 
4.1%) than in the CR group (75.7%  1.6%; P< .001)
(Figure 1, C). There was no difference in the reintervention-
free survival rate between the 2 groups (P ¼ .179).
Results of the Cox model for all-cause mortality are pre-
sented in Table 3. The independent predictors of all-cause
mortality were age, CRF (hemodialysis dependent anddiovascular Surgery c Volume 147, Number 4 1227
TABLE 1. Perioperative characteristics
Variables CR (N ¼ 1388) IR (N ¼ 216)
P
value
Age, y* 68  9 68  9 .250
Female sex 389 (28) 52 (24) .252
BSA, m2* 1.61  0.17 1.60  0.16 .431
NYHA class 3 260 (19) 51 (24) .096
Unstable angina 311 (22) 49 (23) .930
Preoperative IABP 49 (3.5) 10 (4.6) .435
Emergency operation 103 (7.4) 26 (12) .030
Previous MI 579 (42) 114 (53) .002
Recent MI (within 90 d) 133 (9.6) 25 (12) .389
CHF 176 (13) 37 (17) .084
LVEF,%* 62.0  11.7 58.8  14.2 <.001
AF 63 (4.5) 10 (4.6) .862
Diseased vessels
1- Or 2-vessel disease 459 (33) 39 (18) <.001
3-Vessel disease 929 (67) 177 (82) <.001
Left main disease 620 (45) 87 (40) .239
1 Total occlusion 465 (34) 129 (60) <.001
No. of significant lesions* 4.0  1.7 4.3  1.4 .049
Previous PCI 604 (44) 94 (44) 1.000
Previous cardiac surgery 29 (2.1) 5 (2.3) .799
CRF (creatinine>200 mmol/L) .046
Nonhemodialysis dependent 29 (2.1) 5 (2.3)
Hemodialysis dependent 66 (4.8) 19 (8.8)
Diabetes mellitus .179
Diet or oral drug use 476 (34.3) 84 (38.9)
Insulin use 163 (11.7) 30 (13.9)
Hypertension 925 (67) 157 (73) .086
Hypercholesterolemia 778 (56) 110 (51) .163
COPD 36 (2.6) 7 (3.2) .504
Extracardiac arteriopathy 297 (21) 55 (26) .185
CVA 240 (17) 48 (22) .086
Logistic EuroSCOREy 3.1 (1.7-5.7) 4.0 (2.1-8.2) <.001
No. of anastomoses* 3.8  1.1 2.9  0.9 <.001
Conduits
LITA 1337 (96) 205 (95) .340
RITA 1121 (81) 158 (73) .014
BITA 1096 (79) 152 (70) .006
GEA 530 (38) 34 (16) <.001
SVG 618 (45) 51 (24) <.001
Radial artery 47 (3.4) 4 (1.9) .299
Conversion to CCAB 1 (0.1) 5 (2.3) <.001
Postoperative angiography
(N ¼ 3914 grafts)z,x
.316
Fitzgibbon A 3291/3512 (94) 375/402 (93)
Fitzgibbon B 132/3512 (3.8) 20/402 (5.0)
Fitzgibbon O 89/3512 (2.5) 7/402 (1.7)
In-hospital mortality 9 (0.6) 4 (1.9) .085
Hospital length of stay, dy 14 (12-19) 15 (12-21) .323
Values are given as number (percentage) unless otherwise indicated. CR, Complete
revascularization; IR, incomplete revascularization; BSA, body surface area; NYHA,
New York Heart Association; IABP, intra-aortic balloon pump; MI, myocardial in-
farction; CHF, congestive heart failure; LVEF, left ventricular ejection fraction;
AF, atrial fibrillation; PCI, percutaneous coronary intervention; CRF, chronic renal
failure; COPD, chronic obstructive pulmonary disease; CVA, cerebrovascular acci-
dent; EuroSCORE, European System for Cardiac Operative Risk Evaluation;
LITA, left internal thoracic artery; RITA, right internal thoracic artery; BITA, bilateral
=
TABLE 2. Multivariable analysis: predictors of incomplete
revascularization
Variables
Odds
Ratio 95% CI
P
value
1 Total occluded lesion(s) 2.81 2.04-3.87 <.001
BSA, m2 0.17 0.08-0.37 <.001
3-Vessel disease 1.70 1.18-2.44 .004
Emergency operation 1.73 1.05-2.41 .032
Diabetes mellitus (diet or oral drug use) 1.42 1.02-196 .035
Female sex 1.56 1.02-2.41 .042
LVEF,% 0.99 0.98-1.00 .110
Hypertension 1.29 0.92-1.81 .134
CVA 1.26 0.87-1.84 .224
CRF (hemodialysis dependent) 1.43 0.80-2.55 .231
CHF 0.77 0.49-1.20 .240
Age 0.99 0.98-1.01 .243
Diabetes mellitus (insulin use) 1.30 0.81-2.09 .274
Hypercholesterolemia 0.85 0.62-1.17 .320
AF 1.25 0.61-2.54 .548
Left main disease 1.08 0.79-1.49 .623
Previous cardiac surgery 1.17 0.43-3.19 .755
Extracardiac arteriopathy 1.06 0.74-1.52 .756
Previous MI 1.05 0.74-1.49 .790
Previous PCI 1.00 0.74-1.37 .979
CRF (non–hemodialysis dependent) 1.01 0.37-2.76 .989
COPD 1.00 0.42-2.40 .996
CI, Confidence interval; BSA, body surface area; LVEF, left ventricular ejection frac-
tion; CVA, cerebrovascular accident; CRF, chronic renal failure; CHF, congestive
heart failure; AF, atrial fibrillation;MI, myocardial infarction; PCI, percutaneous cor-
onary intervention; COPD, chronic obstructive pulmonary disease.
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Dnon–hemodialysis dependent), extracardiac arteriopathy,
diabetes mellitus (insulin use), saphenous vein graft, and
IR (HR, 1.80; 95% CI, 1.15-2.81; P ¼ .010), whereas the
number of anastomoses and LVEFs was associated with
a significantly better outcome.
In the propensity score analysis, the patients were strati-
fied into 10 subgroups based on the estimated probabilities
of IR occurring to interpret accurate differences observed in
outcome. Applying the stratified Cox regression analysis,
the all-cause mortality was also higher in the IR patients
than in the CR patients (HR, 1.75; 95% CI, 1.10-2.79).
Also, by the stratified log-rank test, a significant difference
was obtained between the IR and CR patients (P ¼ .019).
Figure 2 shows the Kaplan-Meier curves of the patent and
occlusion groups. All-cause mortality did not differ be-
tween the groups (P ¼ .461). On the other hand, the
event-free survival rates for MACCE and reintervention
were significantly lower in the occlusion group than in the
patent group (both log-rank P<.001) (Figure 2, A and B).
Immediately after angiography, many revascularizationsinternal thoracic arteries; GEA, gastroepiploic artery; SVG, saphenous vein graft;
CCAB, conventional coronary artery bypass. *Data are given as mean  SD. yData
are given as median (interquartile range). zOverall, 1521 patients underwent postop-
erative angiography (3914 grafts). xData are given as number/total (percentage).
gery c April 2014
FIGURE 1. Kaplan-Meier estimates for the CR and IR groups. A, Survival curve for all-cause mortality. B, Event-free survival curve for cardiac death. C,
Event-free survival curve for MACCE. CR, Complete revascularization; IR, incomplete revascularization;MACCE, major adverse cardiac and cerebrovas-
cular events.
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reoperation). However, when the patients who underwent
in-hospital reinterventions were excluded, the event-free
survival rate for reintervention was still lower in the occlu-
sion group than in the patent group (P¼ .038) (Figure 2,C).
The Cox models revealed that graft occlusion was an inde-
pendent risk factor for both all the reinterventions (HR,
5.49; 95% CI, 3.44-8.77; P<.001) and the reintervention
after discharge (HR, 2.41; 95% CI, 1.30-4.47; P ¼ .005).
Interaction between IR and graft occlusion was not signifi-
cant in the regression models for either all-cause mortality
or reintervention (P ¼ .423 and P ¼ .511, respectively).DISCUSSION
This study has clearly shown that IR was associated with
decreased midterm survival after OPCAB surgery, whereas
CR was not relevant to increased hazard of reintervention.The Journal of Thoracic and CarIn contrast, graft occlusion was not associated with overall
survival, but was relevant to increased hazard of MACCE or
reintervention. IR was also an independent risk factor for
all-cause mortality using the Cox model, whereas graft oc-
clusion was an independent risk factor for reintervention.
Because the advantage of CR was not limited to groups of
patients with low probabilities of IR occurring, there is no
evidence of major selection bias, and the results previously
stated are not altered by the propensity score analyses.Completeness of Revascularization
CR has been recognized as a surgical mantra since the era
of CCAB.5,6 Alamanni et al12 found that patients with IR
experienced perioperative myocardial infarction more fre-
quently than those without IR. Other investigators reported
that IR was associated with long-term mortality after
CCAB18 and OPCAB.7,8 The findings of this study are indiovascular Surgery c Volume 147, Number 4 1229
TABLE 3. Cox hazards analysis for all-cause mortality
Variables
All-cause mortality
Hazard
ratio 95% CI
P
value
Age 1.08 1.06-1.10 <.0001
CRF (hemodialysis dependent) 4.39 2.72-7.06 <.0001
CRF (non–hemodialysis dependent) 3.31 1.70-6.41 <.0001
Extracardiac arteriopathy 1.79 1.29-2.49 .001
No. of anastomoses 0.77 0.64-0.93 .005
LVEF,% 0.98 0.97-0.99 .005
Diabetes mellitus (insulin use) 1.80 1.17-2.77 .007
Incomplete revascularization 1.80 1.15-2.81 .010
SVG 1.51 1.01-2.24 .043
3-Vessel disease 0.66 0.41-1.06 .086
GEA 1.44 0.93-2.20 .099
COPD 1.76 0.89-3.48 .104
BITA 1.40 0.92-2.12 .117
Hypercholesterolemia 0.79 0.58-1.09 .149
CHF 1.30 0.87-1.94 .196
CVA 1.24 0.87-1.76 .229
Diabetes mellitus (diet or oral drug use) 1.22 0.86-1.71 .262
Conversion to CCAB 2.19 0.51-9.44 .292
Previous MI 0.86 0.62-1.21 .387
1 Total occluded lesion(s) 0.86 0.61-1.21 .397
Previous cardiac surgery 1.53 0.55-4.27 .415
Female sex 1.18 0.76-1.85 .460
BSA 0.73 0.20-2.64 .625
AF 1.16 0.62-2.18 .651
Left main disease 0.94 0.68-1.30 .705
Hypertension 1.05 0.74-1.48 .789
Emergency operation 0.95 0.57-1.59 .850
Previous PCI 0.98 0.72-1.34 .883
CI, Confidence interval; CRF, chronic renal failure; LVEF, left ventricular ejection
fraction; SVG, saphenous vein graft;GEA, right gastroepiploic artery;COPD, chronic
obstructive pulmonary disease; BITA, bilateral internal thoracic arteries; CHF, con-
gestive heart failure; CVA, cerebrovascular accident; CCAB, conventional coronary
artery bypass; MI, myocardial infarction; BSA, body surface area; AF, atrial fibrilla-
tion; PCI, percutaneous coronary intervention.
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curves diverged over time, although the follow-up was
relatively short. On the other hand, 2 investigators reported
no difference in survival between CR and IR patients.19,20
This discrepancy may be partly the result of the
difference in patient selection. Rastan et al19 limited the
study subjects to patients with left internal thoracic artery-
LAD bypasses.
This retrospective study could not identify the reason
why IR is associated with midterm survival. However, one
possible explanation is that the poorer outcome of the IR
group might be ascribed to the differences in patient charac-
teristics. Osswald et al21 noted that advanced coronary ar-
tery disease and other comorbidities might account for the
higher risk of death after IR. Inasmuch as multivariable lo-
gistic regression analysis revealed that the predictors for IR
were 1 or more total occluded lesion(s), lower BSA,
3-vessel disease, emergency operation, diabetes mellitus1230 The Journal of Thoracic and Cardiovascular Sur(diet or oral drug use), and female sex (Table 2), IR might
serve as a surrogate variable for previous MI. Ischemic car-
diomyopathy is well recognized as a predictor of long-term
survival after coronary artery bypass grafting.22 It is also
possible that higher-risk profiles of the IR group account
for the decreased survival.
O’Connor et al23 reported that lower BSA and female sex
are associated with coronary diameter. Although IR could
result from a difficulty of anastomoses in small coronary ar-
teries, myocardial viability may also account for its influ-
ence on midterm survival.5 In this study, most segments
left unbypassed were in the RCA and LCx systems
(98%). This might partly reflect our grafting strategy.
Some of these arteries were left unbypassed because of an
occlusion on preoperative angiography. However, they
may have been more important than originally recognized.6
In addition, patients with poor left ventricular function and
predominantly viable myocardium may have a better out-
come after revascularization than those with less viability.24
However, assessments, such as positron emission tomogra-
phy,25 were not routinely undertaken preoperatively in our
series. Outcomes might be expected to improve if the dis-
eased vessels were revascularized in their territories with
‘‘hibernating myocardium.’’25
Graft Patency
Several studies10,11 reported that reintervention at
follow-up was more frequent among patients undergoing
OPCAB than among those undergoing CCAB. Wijeysun-
dera et al,13 in their meta-analysis, reported that the mean
graft number was 0.19 lower in the OPCAB arm in the ran-
domized studies, and both the randomized and the retro-
spective studies showed trends toward increased repeated
revascularization. The possible causes are IR and the lower
patency rate in OPCAB patients. However, the relative con-
tributions of the 2 possible causes have not been deter-
mined.10,12,13 Lopes et al9 have recently reported that vein
graft failure is associated with repeat revascularization after
an angiographic follow-up of the Project of Ex Vivo Vein
Graft Engineering via Transfection (PRVENT) IV cohort.
In our study, similar to their results, the event-free rates
for MACCE or reintervention were both significantly lower
in the occlusion group (P<.001 for both). Twenty-four pa-
tients received PCI, and 1 patient underwent a redo opera-
tion immediately after graftgraphy (18 PCIs and 1 surgery
in the occlusion group), whereas there were 63 PCIs and
3 redo surgeries after discharge. The differences in the
event-free rates for MACCE or reintervention between the
occlusion and patent groups were mainly due to the early
PCI procedures. However, even if in-hospital repeated inter-
ventions were excluded, the event-free rate for reinterven-
tion was still lower in the occlusion group (P ¼ .038).
Achievement of higher patency, in addition to CR, might
be expected to lower the rate of adverse cardiac events. Itgery c April 2014
FIGURE 2. Kaplan-Meier estimates for the patent and occlusion groups. A, Event-free survival curve for MACCE. B, Event-free survival
curve for reintervention. C, Event-free survival curve for reintervention after discharge. MACCE, Major adverse cardiac and cerebrovascular
event.
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tion in OPCAB surgery.9,16
Limitations
First, because this was a retrospective observational
study, confounding biases might not have been eliminated.
Multivariable analyses were used in the study to control for
differences in prognostic factors. Also, our propensity score
analyses did not suggest any substantial selection bias; nev-
ertheless, some unmeasured factors (eg, more complex cor-
onary pathology) were inevitable,8 and any causal effects
cannot be stated. Second, this study was from a single sur-
geon and a single center, limiting the generalizability of
these results. Third, graftgraphy was performed using 2 mo-
dalities: catheter-based angiography and multidetector
CT. MDCT is generally used in daily practice, butThe Journal of Thoracic and Carcatheter-based coronary angiography remains the gold stan-
dard. In addition, the results of those 2 examinations were
read by 2 different teams. Although times 0 of the
Kaplan-Meier curves for the occlusion and patent groups
should be the time of angiographic evaluation, the actual
dates of the angiography were not available from our
database. Fourth, although interaction between IR and
occlusion was not significant, it might be owing to the
few patients in the IR and occlusion groups. Fifth, the dom-
inancy of coronary systems or the number of class C lesions
was not noted in our database, and the assessment of in-
farcted area viability was not routinely performed. Sixth,
each patient could not be identified as too small or diffusely
diseased, because several patients had more than one reason
for incomplete revascularization and some others had no
reason given in the operator’s note. Finally, because onlydiovascular Surgery c Volume 147, Number 4 1231
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D77 patients underwent on-pump CABG in our institution
during the study period, we could not compare the angio-
graphic results between OPCAB and on-pump CABG.
CONCLUSIONS
Incomplete revascularization was relevant to higher mid-
term mortality after OPCAB, whereas the risks of MACCE
and reintervention were higher for patients with occluded
grafts. The surgical mantra of CR remains pertinent, even
in OPCAB. CR, coupled with achievement of a higher pa-
tency rate, could be expected to improve outcomes at
follow-up after OPCAB surgery.
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